What is Acusphere, Inc. (ACUS) stock price today?

Acusphere, Inc. (ACUS) is currently trading at $0.00.

What is ACUS P/E ratio?

Acusphere, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ACUS return on equity (ROE)?

Acusphere, Inc.'s return on equity (ROE) is -225.00%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Acusphere, Inc.'s market cap?

Acusphere, Inc. has a market capitalization of $49.

OTC · Drug Manufacturers - Specialty & Generic

Acusphere, Inc. (ACUS) Stock

$0.00 OTC: ACUS Healthcare

Acusphere, Inc. is a pharmaceutical firm specializing in the creation and market launch of cardiovascular treatments.

Valuation

Metric	Value
Price	$0.00
Market Cap	$49
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	1.38
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-225.00%
ROA	-70.66%
ROCE	158.84%
Gross Margin	1766.67%
Operating Margin	1766.67%
Net Margin	-1800.00%
Debt/Equity	0.75
Current Ratio	1.27

Annual Financials (USD)

Metric	2003	2004	2005	2006	2007
Revenue	$0	$2.0M	$3.0M	$2.0M	$3.0M
Operating Profit	$20.0M	$30.0M	$46.0M	$62.0M	$53.0M
Net Profit	$-22.0M	$-30.0M	$-45.0M	$-61.0M	$-54.0M
EPS	$-52.35	$-19.20	$-23.61	$-22.13	$-12.60
Op Margin	—	1774.9%	1346.8%	3496.9%	1977.0%

Balance Sheet (USD)

Metric	2003	2004	2005	2006	2007
Total Assets	$59.0M	$62.0M	$96.0M	$95.0M	$52.0M
Total Liabilities	$5.0M	$16.0M	$38.0M	$36.0M	$28.0M
Cash	$55.0M	$45.0M	$51.0M	$60.0M	$26.0M
Borrowings	$1.0M	$4.0M	$21.0M	$22.0M	$18.0M

Cash Flow (USD)

Metric	2003	2004	2005	2006	2007
Operating Cash Flow	$-16.0M	$-19.0M	$-31.0M	$-48.0M	$-42.0M
Investing Cash Flow	$-1.0M	$-25.0M	$-66.0M	$-2.0M	$-2.0M
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$47.0M	$-9.0M	$6.0M	$9.0M	$-34.0M
Free Cash Flow	$-16.0M	$-32.0M	$-64.0M	$-49.0M	$-43.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.18
FCF Yield	-87148979.59%
Quick Ratio	1.45
Interest Coverage	25.67
Return 1Y	0.00%
Return 3Y	0.00%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AQSZFAequus Pharmaceuticals Inc.	$0.00	—	-1.52	$159161	0.00%
BBBTBlack Bird Biotech, Inc.	$0.00	—	-0.02	$98405	0.00%
DVLPGolden Developing Solutions, Inc.	$0.00	—	0.00	$1413	0.00%
IRBSIR Biosciences Holdings Inc.	$0.00	—	0.00	$128122	0.00%
MCICMulticorp International, Inc.	$0.00	—	-35.44	$262478	0.00%

About Acusphere, Inc.

Acusphere, Inc. is a pharmaceutical firm specializing in the creation and market launch of cardiovascular treatments. Its flagship product is Imagify (perflubutane polymer microspheres), a cardiovascular medication designed to assess myocardial perfusion and aid in the diagnosis of coronary artery disease. This drug is administered as an injectable suspension. Initially established as Polymers For Medicine, Inc., the organization rebranded as Acusphere, Inc. in March 2004. Founded in 1993, the company maintains its headquarters in Watertown, Massachusetts.

Acusphere, Inc. (ACUS) stock trades at $0.00 with a market capitalization of $49. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 1.38. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Acusphere, Inc. generates a return on equity (ROE) of -225.00%, return on capital employed of 158.84%, an operating margin of 1766.67%, a net profit margin of -1800.00%.

Official website: www.acusphere.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides